Russell Investments Group Ltd. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,242,862 shares of the healthcare conglomerate's stock after buying an additional 110,302 shares during the period. UnitedHealth Group accounts for approximately 0.9% of Russell Investments Group Ltd.'s holdings, making the stock its 11th biggest position. Russell Investments Group Ltd. owned 0.14% of UnitedHealth Group worth $628,842,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of UNH. Wallace Capital Management Inc. boosted its position in UnitedHealth Group by 0.9% during the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate's stock valued at $1,239,000 after purchasing an additional 19 shares during the period. Western Pacific Wealth Management LP grew its position in shares of UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after acquiring an additional 19 shares during the last quarter. MCF Advisors LLC lifted its position in UnitedHealth Group by 0.8% in the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock valued at $1,304,000 after purchasing an additional 20 shares during the last quarter. Axiom Financial Strategies LLC grew its position in UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after purchasing an additional 20 shares during the last quarter. Finally, Richwood Investment Advisors LLC raised its holdings in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after buying an additional 20 shares during the last quarter. Institutional investors own 87.86% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have weighed in on UNH. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, KeyCorp reaffirmed an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $629.32.
Read Our Latest Analysis on UnitedHealth Group
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm's stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company's stock.
UnitedHealth Group Stock Down 2.9 %
NYSE:UNH traded down $15.50 during trading hours on Friday, hitting $524.94. 9,914,705 shares of the stock traded hands, compared to its average volume of 4,256,040. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $480.17 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.61. The firm has a 50 day moving average price of $509.24 and a 200 day moving average price of $541.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.83 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group's dividend payout ratio is 54.19%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.